"
Familial versus Sporadic Breast Cancer: Different Treatments for Similar Tumors?"
written by Ellen G. Engelhardt, Mieke Kriege, Maartje J. Hooning, Caroline Seynaeve, Rob A. E. M. Tollenaar, Christina J. van Asperen, Margreet G. E. M. Ausems, Lonneke V. van de Poll-Franse, Stella Mook, Senno Verhoef, Matti A. Rookus, HEBON Collaborators, Marjanka K. Schmidt,
published by
Advances in Breast Cancer Research,
Vol.4 No.4, 2015
has been cited by the following article(s):
|
[1]
|
Galangin/β-Cyclodextrin Inclusion Complex as a Drug-Delivery System for Improved Solubility and Biocompatibility in Breast Cancer Treatment
Molecules,
2022
DOI:10.3390/molecules27144521
|
|
|
|
|
[2]
|
Galangin/β-Cyclodextrin Inclusion Complex as a Drug-Delivery System for Improved Solubility and Biocompatibility in Breast Cancer Treatment
Molecules,
2022
DOI:10.3390/molecules27144521
|
|
|
|
|
[3]
|
Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women
JNCI: Journal of the National Cancer Institute,
2017
DOI:10.1093/jnci/djw329
|
|
|
|